Journal of Skin and Stem Cell

Published by: Kowsar

Concentrated Extracts of Cassia fistula Versus Intralesional Injection of Meglumine Antimoniate in Treatment of Acute Cutaneous Leishmaniasis

Fariba Jaffary 1 , Mohammad Ali Nilforoushzadeh 1 , 2 , * , Shahram Moradi 1 , Roya Derakhshan 1 and Nazli Ansari 1
Authors Information
1 Skin Diseases and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
2 Skin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, Iran
Article information
  • Journal of Skin and Stem Cell: May 25, 2014, 1 (1); e16631
  • Published Online: May 15, 2014
  • Article Type: Research Article
  • Received: November 13, 2013
  • Revised: January 24, 2014
  • Accepted: March 4, 2014
  • DOI: 10.17795/jssc16631

To Cite: Jaffary F, Nilforoushzadeh M A, Moradi S, Derakhshan R, Ansari N. Concentrated Extracts of Cassia fistula Versus Intralesional Injection of Meglumine Antimoniate in Treatment of Acute Cutaneous Leishmaniasis, J Skin Stem Cell. 2014 ; 1(1):e16631. doi: 10.17795/jssc16631.

Copyright © 2014, Skin and Stem Cell Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Desjeux P. The increase in risk factors for leishmaniasis worldwide. Trans R Soc Trop Med Hyg. 2001; 95(3): 239-43[DOI]
  • 2. Ardehaly S, Azadeh B, Javadian E, Rezaei HR. Leishmaniasis parasite and leishmaniasis. 1984;
  • 3. Grogl M, Thomason TN, Franke ED. Drug resistance in leishmaniasis: its implication in systemic chemotherapy of cutaneous and mucocutaneous disease. Am J Trop Med Hyg. 1992; 47(1): 117-26[PubMed]
  • 4. Croft SL. Monitoring drug resistance in leishmaniasis. Trop Med Int Health. 2001; 6(11): 899-905[PubMed]
  • 5. Saeebi A. Parasitic diseases in Iran. 1984;
  • 6. Akanmu MA, Iwalewa EO, Elujoba AA, Adelusola KA. Toxicity potentials of Cassia fistula fruits as laxative with reference to Senna. Afr J Biomed Res. 2004; 7(1): 23-6
  • 7. Yadava RN, Verma V. A new biologically active flavone glycoside from the seeds of Cassia fistula (Linn.). J Asian Nat Prod Res. 2003; 5(1): 57-61[DOI][PubMed]
  • 8. Perumal Samy R, Ignacimuthu S, Sen A. Screening of 34 Indian medicinal plants for antibacterial properties. J Ethnopharmacol. 1998; 62(2): 173-81[DOI]
  • 9. Luximon-Ramma A, Bahorun T, Soobrattee MA, Aruoma OI. Antioxidant activities of phenolic, proanthocyanidin, and flavonoid components in extracts of Cassia fistula. J Agric Food Chem. 2002; 50(18): 5042-7[PubMed]
  • 10. Sartorelli P, Andrade SP, Melhem MS, Prado FO, Tempone AG. Isolation of antileishmanial sterol from the fruits of Cassia fistula using bioguided fractionation. Phytother Res. 2007; 21(7): 644-7[DOI][PubMed]
  • 11. Mohebali M, Chenari A, Nazari MR. Effect of Cassia fistula on leishmania major ulcers in small laboratory with mice. Pajouhandeh Q Res J. 1999; 1: 14-9
  • 12. Chauhan N, Bairwa R, Sharma K, Chauhan N. Review on cassia fistula. IJRAP. 2011; 12(2): 426-30
  • 13. Jaffary F. Nilforoushzadeh M.A, Ansari N, Rahimi M. Treatment of cutaneous leishmaniasis: cassia fistula fruit gelintralesionalglucantime Vs. placebo gel- intralesional.glucantime combination. Tehran Univ Med J. 2010; : 705-11
  • 14. Ilavarasan R, Mallika M, Venkataraman S. Anti-inflammatory and antioxidant activities of Cassia fistula Linn bark extracts. Afr J Trad. 2005; 2(1): 70-85
  • 15. Senthil Kumar M, Sripriya R, Vijaya Raghavan H, Sehgal PK. Wound healing potential of Cassia fistula on infected albino rat model. J Surg Res. 2006; 131(2): 283-9[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments